|Articles|September 22, 2016

Managing Medication Adherence to Improve Clinical Trial Quality

External Link - Advanstar westrock Managing Medication Adherence (1).pdf

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content

Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX

ByNicholas Jacobus

November 7th 2025

Image Credit: Adobe Stock Images/Tada Images. The latest selections for the CNPV include therapies for obesity, cancer, sickle cell disease, and drug-resistant tuberculosis.

FDA Continues to Expand National Priority Voucher Program

ByDavy James

November 7th 2025

FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma

ByNicholas Jacobus

November 7th 2025

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

ByThani Jambulingam, PhD

November 7th 2025

Deb Nevins is the Chief Marketing & Strategy Officer at POCN Group. POCN Group, an IQVIA business, is the life-sciences engagement division of POCN.

In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore

ByDeb Nevins

November 7th 2025

Managing Medication Adherence to Improve Clinical Trial Quality

Newsletter

Related Content

Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX

FDA Continues to Expand National Priority Voucher Program

FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore

Trending on PharmExec

Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX